» Articles » PMID: 17501987

An Overview of Tissue Engineering Approaches for Management of Spinal Cord Injuries

Overview
Publisher Biomed Central
Date 2007 May 16
PMID 17501987
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Severe spinal cord injury (SCI) leads to devastating neurological deficits and disabilities, which necessitates spending a great deal of health budget for psychological and healthcare problems of these patients and their relatives. This justifies the cost of research into the new modalities for treatment of spinal cord injuries, even in developing countries. Apart from surgical management and nerve grafting, several other approaches have been adopted for management of this condition including pharmacologic and gene therapy, cell therapy, and use of different cell-free or cell-seeded bioscaffolds. In current paper, the recent developments for therapeutic delivery of stem and non-stem cells to the site of injury, and application of cell-free and cell-seeded natural and synthetic scaffolds have been reviewed.

Citing Articles

The evolution of the global COVID-19 epidemic in Morocco and understanding the different therapeutic approaches of chitosan in the control of the pandemic.

Ait Hamdan Y, El Amerany F, Desbrieres J, Aghrinane A, Oudadesse H, Rhazi M Polym Bull (Berl). 2022; :1-27.

PMID: 36466080 PMC: 9685138. DOI: 10.1007/s00289-022-04579-3.


Preliminary application of native Nephila edulis spider silk and fibrin implant causes granulomatous foreign body reaction in vivo in rat's spinal cord.

Koop F, Strauss S, Peck C, Aper T, Wilhelmi M, Hartmann C PLoS One. 2022; 17(3):e0264486.

PMID: 35286342 PMC: 8920256. DOI: 10.1371/journal.pone.0264486.


The corticospinal tract structure of collagen/silk fibroin scaffold implants using 3D printing promotes functional recovery after complete spinal cord transection in rats.

Li X, Zhu X, Liu X, Xu H, Jiang W, Wang J J Mater Sci Mater Med. 2021; 32(4):31.

PMID: 33751254 PMC: 7985105. DOI: 10.1007/s10856-021-06500-2.


Hydrogel-assisted neuroregeneration approaches towards brain injury therapy: A state-of-the-art review.

Kornev V, Grebenik E, Solovieva A, Dmitriev R, Timashev P Comput Struct Biotechnol J. 2018; 16:488-502.

PMID: 30455858 PMC: 6232648. DOI: 10.1016/j.csbj.2018.10.011.


Hydrogels and Cell Based Therapies in Spinal Cord Injury Regeneration.

Assuncao-Silva R, Gomes E, Sousa N, Silva N, Salgado A Stem Cells Int. 2015; 2015:948040.

PMID: 26124844 PMC: 4466497. DOI: 10.1155/2015/948040.


References
1.
Firouzi M, Moshayedi P, Saberi H, Mobasheri H, Abolhassani F, Jahanzad I . Transplantation of Schwann cells to subarachnoid space induces repair in contused rat spinal cord. Neurosci Lett. 2006; 402(1-2):66-70. DOI: 10.1016/j.neulet.2006.03.070. View

2.
TOBIAS C, Dhoot N, Wheatley M, Tessler A, Murray M, Fischer I . Grafting of encapsulated BDNF-producing fibroblasts into the injured spinal cord without immune suppression in adult rats. J Neurotrauma. 2001; 18(3):287-301. DOI: 10.1089/08977150151070937. View

3.
Bamber N, Li H, Lu X, Oudega M, Aebischer P, Xu X . Neurotrophins BDNF and NT-3 promote axonal re-entry into the distal host spinal cord through Schwann cell-seeded mini-channels. Eur J Neurosci. 2001; 13(2):257-68. View

4.
Yoshii S, Oka M, Shima M, Taniguchi A, Taki Y, Akagi M . Restoration of function after spinal cord transection using a collagen bridge. J Biomed Mater Res A. 2004; 70(4):569-75. DOI: 10.1002/jbm.a.30120. View

5.
Blits B, Bunge M . Direct gene therapy for repair of the spinal cord. J Neurotrauma. 2006; 23(3-4):508-20. DOI: 10.1089/neu.2006.23.508. View